Taipei Medical University Institutional Repository:Item 987654321/64561
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 45422/58598 (78%)
造访人次 : 2539375      在线人数 : 224
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/64561


    题名: 再生醫療雙法難產對於台灣生技公司股價之影響
    The Impact of the Stalled Dual Laws on Regenerative Medicine on the Stock Prices of Taiwanese Biotech Companies
    作者: 施旻瑩
    Shih, Ming-Ying
    贡献者: 管理學院生物科技高階管理碩士在職專班
    蕭育仁
    关键词: 再生醫療雙法;生技產業;股價影響;政策變動
    Regenerative Medicine;Biotechnology industry;Stock Price Impact;Policy Changes
    日期: 2024-01-05
    上传时间: 2024-11-06 10:42:01 (UTC+8)
    摘要: 本論文深入探討再生醫療雙法對台灣生技產業股價的影響，透過對法案提出、審議和二讀未果等關鍵事件的深入分析，揭示了市場在不同階段的細緻反應。第一章中，介紹再生醫療雙法的制定背景，強調政策的重要性。第二章進行詳盡的文獻回顧，聚焦全球相關法規的影響，提供了本研究的理論依據。第三章闡述研究方法，強調事件研究法的優勢和資料收集的細節。在第四章中，本研究呈現了具體的實證結果，發現市場對再生醫療雙法的反應呈現出時間演變的特點，並進一步挖掘了市場受到影響的具體原因。最後，第五章的結論與建議提供了深刻的洞察，強調生技公司應即時因應政策變動，建立風險管理策略，並與政府積極互動，以促進產業的健康發展。
    This thesis delves into the nuanced impact of the Regenerative Medicine Act on the stock prices of Taiwan's biotechnology industry. Through an in-depth analysis of key events such as the proposal, review, and unsuccessful second reading of the bill, it unveils the market's intricate responses at different stages. In Chapter 1, the introduction emphasizes the significance of policy by outlining the background of the Regenerative Medicine Act. Chapter 2 conducts a comprehensive literature review, focusing on the global impact of relevant regulations, providing a robust theoretical foundation for this study. Chapter 3 elucidates the research methods, emphasizing the advantages of the event study approach and detailing data collection. In Chapter 4, this research presents concrete empirical results, discovering the evolving nature of the market's response to the Regenerative Medicine Act and further exploring the specific reasons behind market influence. Finally, Chapter 5's conclusion and recommendations provide profound insights, emphasizing that biotech companies should respond promptly to policy changes, establish risk management strategies, and actively engage with the government to foster industry development.
    描述: 碩士
    指導教授：蕭育仁
    口試委員：蕭育仁
    口試委員：周冠男
    口試委員：張巧真
    附注: 論文公開日期：2024-01-17
    数据类型: thesis
    显示于类别:[生物科技高階管理碩士專班] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML77检视/开启


    在TMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    著作權聲明 Copyright Notice

    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈